Recent FATE Stock Price | FATE Stock Predictions | |
$7.34 | -1.50% |
$7.23 |
Recent FATE Analyst Ratings Breakdown, Making FATE Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 6 | 6 | 6 | 6 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 13 | 13 | 13 | 13 |
Sell ratings: | 1 | 1 | 1 | 1 |
Strong sell ratings: | 1 | 1 | 1 | 1 |
Average rating: | 2.57 | 2.57 | 2.57 | 2.57 |
For the FATE stock predictions from the analysts covering Fate Therapeutics Inc, we have collected all of the individual FATE stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 13 different analysts covering FATE (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since FATE stock predictions may vary widely, another useful metric to consider is the median FATE stock prediction, which represents the price at which half of the analysts
made FATE stock predictions that were higher and half made FATE stock predictions that were lower. This makes for a different take on the FATE stock predictions out there, as compared to average or mean.
And that median across all the individual FATE stock predictions was: $7.0 as of 2024-03-29.
The very highest of the FATE stock predictions for one year price target was $12.0, while the very lowest of the FATE stock predictions in the analyst group was
$2.0 (with a standard deviation of $2.521). Get the latest Zacks research report on FATE — FREE
Find out: FATE next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
ACEL Stock Predictions
REVG Stock Predictions
TMHC Stock Predictions
SWI Stock Predictions
CHMG Stock Predictions
CTSO Stock Predictions
EPRT Stock Predictions
GDDY Stock Predictions
MIK Stock Predictions
|
|
Hold (2.43 out of 4) 10th percentile
(ranked lower than approx. 90% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |